The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
225 jobs Number of planned job losses
Announcement Date
25 April 2013
Employment effect (start)
Foreseen end date
31 December 2013
Description
US-based pharmaceutical Eli Lily will make 225 people redundant with the closure of its site in Gießen (Hesse). As announced by a spokesperson, the closure is due to a challenging environment, overcapacities and terminating patents. The company announced talks with worker representatives.
Another 1,000 jobs will be axed in the USA, as announced in April. Eli Lily has a global workforce of 38,000 people.
Sources
25 April 2013: Gießener Allgemeine (Online)
Citation
Eurofound (2013), Eli Lilly, Closure in Germany, factsheet number 75318, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/75318.